alexa ISG15: A Potential Target For The Diagnosis And Treatment Of Breast Cancer
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

Global Cancer Conference & Medicare Summit
September 15-17, 2014 Hyderabad International Convention Centre, India

Shyamal Dilip Desai
Keynote: J Cancer Sci Ther
DOI: 10.4172/1948-5956.S1.036
Breast cancer metastasis is a major clinical problem worldwide. The gap in knowledge of the ?root causes? of progression of this disease is currently hindering the efforts in finding cure for the metastatic cancers. The aim is to provide new mechanistic insights to develop clinical treatments that can slow or prevent the progression of breast cancer. Using a breast cancer cell culture model, author and her group has identified an ubiquitin-like protein called ISG15 (Interferon-Stimulated Gene 15) as an important determinant of breast tumorigenesis. The results reveal that elevated levels of ISG15 contribute to breast tumorigenesis by inhibiting the canonical ubiquitin pathway, a master regulator of cell survival and death. ISG15 research has now begun to gain momentum because of the common understanding of its elevated expression in most human malignancies. The author will relate the current understanding of the ISG15 pathway and its emerging importance in the etiology of breast cancer development and progression. The views on the future potential for application of ISG15 as a biomarker for cancer diagnosis and treatment in clinic will also be discussed.
Shyamal Dilip Desai obtained her BS, MS, and PhD degrees in Biochemistry from the University of Mumbai, India. She received her Postdoctoral training at the UMDNJ-RWJMS in New Jersey. She currently holds faculty positions as Associate Professor of Biochemistry and Molecular Biology and Associate Professor at the Neuroscience Center of Excellency, at LSU Medical School. She currently serves on the editorial boards of the Journals of Antivirals and Antiretrovirals, Experimental Cell Biology and Medicine, and Cancer Science and Therapy. Her lab is currently engaged in exploring the role of ISG15 in the etiology of cancer and neurological disorder Ataxia Telangiectasia.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version